Stock screenerAll disclosures → EDGAR →
JSPRW
Conviction 0HealthcareScan · Mon, Aug 10, 2026JSPRW$0.0000+0.00%
ResistanceSupportVol 14Vol MA14 3.52K
May 8May 27Jun 15Jul 2Jul 22Aug 7
Jasper Therapeutics, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.jaspertherapeutics.com ↗
Price0.0000
Change+0.00%
Gap—
Rel volume0.00×
Avg volume5.75K
Avg $ vol49.89
SMA 200.0037
SMA 500.0070
SMA 2000.0339
Price vs 50-100.00%
Price vs 200-100.00%
MA stackbearish
50/200 cross—
Supertrendup · -0.0018
RSI (14)47
MACD hist0.00
MACD crossbull · 3d
Stoch %K / %D0 / 30
ADX (14)7
+DI / −DI43 / 41
RSI divergence—
MACD divergence—
ATR %—
ADR %20.31%
52w high0.1400
52w low0.0000
From 52w high-100.00%
Above 52w low—
New 52w highNo
SqueezeOff
Bollinger width612.66%
%B0.34
Donchian pos0.00%
Donchian high0.0135
Donchian low0.0000
AVWAP (52w high)0.0423
vs AVWAP high-100.00%
AVWAP (52w low)0.0510
vs AVWAP low-100.00%
OBV trendUp
Chaikin MF (20)0.46
Today vs 20d0.00×
Avg vol (14d)3.52K
Avg vol (20d)5.75K
Avg $ vol (20d)49.89
Market cap0
RS 3m (vs SPY)-105.70%
RS 6m (vs SPY)-114.11%
RS line new highNo
Trend template0/8
Technical rank—
1 week—
1 month-100.00%
3 months-100.00%
6 months-100.00%
1 year—
YTD-100.00%
P/E0.00
P/B0.00
P/S—
P/FCF—
EPS-3.95
Div yield—
ROE—
ROA-357.82%
Debt/Eq—
Current2.26
EV/EBITDA0.17
Gross margin—
Net margin—
Rev growth—
EPS growth-6.36%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value-14.14M
Revenue—
Net income-1.17M
Gross profit—
Free cash flow—
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out—
Employees22
ListedMon, Sep 27, 2021
Free float—
Float %—
Short interest10.98K
Days to cover1.8d
Short volume—
Squeeze score22 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction0 / 100
Pattern quality—
Tech rank—
Group rank—
Status laneNo active setup
Setup direction—
Pattern family
Resistance0.0147
Support0.0000
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in JSPRW
No recent disclosed trades by Congress in JSPRW. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in JSPRW
No recent insider (Form 4) filings in JSPRW. Insiders must file within two business days of a trade.
SEC filings
EDGAR filings in JSPRW
No recent SEC filings on file for JSPRW.
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.